Showing 1581-1590 of 1841 results for "".
- Lensar Expands Board of Directors with the Appointments of Aimee S. Weisner and Elizabeth G. O’Farrellhttps://modernod.com/news/lensar-expands-board-of-directors-with-the-appointments-of-aimee-s-weisner-and-elizabeth-g-ofarrell/2478817/Lensar announced the expansion of its board of directors to seven members with the appointments of Aimee S. Weisner and Elizabeth G. O’Farrell, effective February 1, 2021. In addition to serving on the company’s Board of Directors, Ms. Weisner will
- Orbis International Announces Mary Jane Jamar as First Chief Human Resources Officerhttps://modernod.com/news/orbis-international-announces-mary-jane-jamar-as-first-chief-human-resources-officer/2478605/Orbis has named Mary Jane Jamar as the organization’s first Chief Human Resources Officer (CHRO). In this capacity, Ms. Jamar will also join and play a critical role on the Orbis Executive Leadership Team.
- PolyActiva Appoints Tracy Valorie to its Board of Directorshttps://modernod.com/news/polyactiva-appoints-tracy-valorie-to-its-board-of-directors/2478481/PolyActiva announced the appointment of experienced ophthalmic industry expert, Tracy Valorie, as a new member to the company’s Board of Directors. Ms. Valorie is recognized in the industry for her success in building and leading high performing teams a
- ATPO Announces Jessica Barr as New Presidenthttps://modernod.com/news/atpo-announces-jessica-barr-as-new-president/2476160/The Association of Technical Personnel in Ophthalmology (ATPO) has announced that Jessica Barr, COMT, ROUB, is its new president. Ms. Barr is an Implementation Specialist and Education Liaison fo
- Aurion Announces Positive 12-Month Results from Phase 1/2 CLARA Trial of AURN001 Corneal Endothelial Cell Therapyhttps://modernod.com/news/aurion-announces-positive-12-month-results-from-phase-12-clara-trial-of-aurn001-corneal-endothelial-cell-therapy/2484196/Aurion Biotech announced positive 12-month results from its phase 1/2 CLARA clinical trial. The study evaluated the safety, efficacy, and tolerability of AURN001 (neltependocel [human corneal endothelial cells] in combination with Y-27632 rho-kinase inhibitor)
- Bausch + Lomb Retina News, Eventshttps://modernod.com/news/bausch-lomb-retina-news-events/2480011/In advance of this week’s ASRS meeting, Bausch + Lomb Vice President and general manager of Surgical, Chuck Hess, distributed a customer letter to surgeons providing them an update on our progress in retina. The letter is below: Dear Eye Care Professional: At this time last y
- CMS Finalizes Plan to Allow Medicare Advantage Plans to Expand Telehealth Benefitshttps://modernod.com/news/cms-finalizes-plan-to-allow-medicare-advantage-plans-to-expand-telehealth-benefits/2477820/The Trump administration has finalized several changes in Medicare Advantage (MA) and Part D in anticipation of bid submissions on June 1, according to a FierceHealthcare
- Aurion Makes Leadership Announcementshttps://modernod.com/news/aurion-makes-leadership-announcements/2482757/Aurion Biotech announced the appointments of Edward J. Holland, MD, as Chief Medical Officer, and Eris P. Jordan, OD, as Chief Development Officer. Aurion is developing AURN001, an investigational, single-administration, allogeneic cell therapy for the treatment of corneal edema seconda
- Ocular Therapeutix Names Namrata Saroj as Chief Business Officerhttps://modernod.com/news/ocular-therapeutix-names-namrata-saroj-as-chief-business-officer/2482536/Ocular Therapeutix announced that Namrata Saroj, OD, has joined the company as Chief Business Officer (CBO). Dr. Saroj, who has been consulting with Ocular since February 2024, brings extensive experience in clinical development and commercialization in ophthalmology. She cont
- Euclid Vision Announces Winners of its First Resident Scholarship Awardhttps://modernod.com/news/euclid-vision-announces-winners-of-its-first-resident-scholarship-award/2481279/Euclid Vision announced the winners of its inaugural Euclid Resident Scholarship Awards, which recognizes innovation in myopia management and orthokeratology. Optometry Residents Zachary Reynard, OD, University of Alabama at Birmingham (UAB) School of Optometry; Kevin Feng, O